Correlation Between Inozyme Pharma and Icosavax
Can any of the company-specific risk be diversified away by investing in both Inozyme Pharma and Icosavax at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inozyme Pharma and Icosavax into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inozyme Pharma and Icosavax, you can compare the effects of market volatilities on Inozyme Pharma and Icosavax and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inozyme Pharma with a short position of Icosavax. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inozyme Pharma and Icosavax.
Diversification Opportunities for Inozyme Pharma and Icosavax
-0.4 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Inozyme and Icosavax is -0.4. Overlapping area represents the amount of risk that can be diversified away by holding Inozyme Pharma and Icosavax in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Icosavax and Inozyme Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inozyme Pharma are associated (or correlated) with Icosavax. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Icosavax has no effect on the direction of Inozyme Pharma i.e., Inozyme Pharma and Icosavax go up and down completely randomly.
Pair Corralation between Inozyme Pharma and Icosavax
If you would invest 902.00 in Icosavax on August 30, 2024 and sell it today you would earn a total of 0.00 from holding Icosavax or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 1.56% |
Values | Daily Returns |
Inozyme Pharma vs. Icosavax
Performance |
Timeline |
Inozyme Pharma |
Icosavax |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Inozyme Pharma and Icosavax Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Inozyme Pharma and Icosavax
The main advantage of trading using opposite Inozyme Pharma and Icosavax positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inozyme Pharma position performs unexpectedly, Icosavax can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Icosavax will offset losses from the drop in Icosavax's long position.Inozyme Pharma vs. Day One Biopharmaceuticals | Inozyme Pharma vs. X4 Pharmaceuticals | Inozyme Pharma vs. Acumen Pharmaceuticals | Inozyme Pharma vs. Mereo BioPharma Group |
Icosavax vs. Terns Pharmaceuticals | Icosavax vs. Amylyx Pharmaceuticals | Icosavax vs. Acumen Pharmaceuticals | Icosavax vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Other Complementary Tools
CEOs Directory Screen CEOs from public companies around the world | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |